02:19 PM EDT, 10/22/2025 (MT Newswires) -- Armata Pharmaceuticals ( ARMP ) reported Wednesday positive results from a phase 2a study of its AP-SA02 therapy candidate in patients with complicated Staphylococcus aureus bacteremia.

Shares jumped 129% as intraday trading volume catapulted to over 7.1 million shares from a daily average of about 10,000.

Applied DNA Sciences ( BNBX ) said Wednesday it has closed its private investment in public equity financing led by institutional DeFi and TradFi investors, raising about $27 million.

Shares surged 50% as intraday trading volume soared to over 51.6 million from a daily average of roughly 465,000.

Vicor ( VICR ) shares rose 26% intraday after the company overnight reported better-than-expected Q3 results.

More than 2.68 million shares traded intraday, compared with a daily average of about 403,000.

Price: 7.93, Change: +4.46, Percent Change: +128.53